Monday, March 19, 2012 10:16:03 AM
My logical assumption had been that surely players in big pharma know of BIEL because of the potential effect FDA approval on BIEL's pain control devices might have on the chemical pain markets generally. I'm new at this, but it makes sense to me if folks can stop popping lots of pills with serious liver side-effects.
I did not realize I had hit a hot button re Whelan and big pharma in the past until supernova's response - does anyone recall details?
I saw that BIEL hit over 12 cents not long ago, apparently without a reverse split or major announcement - was the big pharma offer chatter the reason - does anyone know? If there was no major announcement at that time, then we know the price went to more than 12 cents on no major announcement. So, doesn't it therefor beg the question as to what it might go to on FDA approval which would be major? Who knows?
Thanks
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM